1. 52PHedgehog pathway influence in the immune escape of tumor cells through PDL-1 modulation. (16th September 2018) Authors: Napolitano, F; Di Mauro, C; Pesapane, A; Rosa, R; D'Amato, V; Santaniello, A; Servetto, A; Formisano, L; Marciano, R; Bianco, R Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 60PInvestigating the role of nuclear sphingosine kinase 1 (SphK1) in lung cancer. (5th March 2018) Authors: Napolitano, F; Rosa, R; D'Amato, V; Orsini, R C; Ciciola, P; Di Mauro, C; Santaniello, A; Marciano, R; De Placido, S; Bianco, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 75PRole of p21-activated kinase (PAK) in K-RAS mutant human colorectal cancer models. (5th March 2018) Authors: Orsini, R C; D'Amato, V; Rosa, R; Di Mauro, C; Ciciola, P; Servetto, A; Napolitano, F; Marciano, R; De Placido, S; Bianco, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CP-196 Axitinib induced blood pressure elevation associated with a longer progression free survival: A retrospective analysis. (14th February 2016) Authors: Langella, R; Festinese, F; Nurra, S; Lanzo, G; Togliardi, E; Della Costanza, C; Antonacci, G; Di Mauro, C; Mazzer, M; Saibene, G Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DI-065 Safety of dabrafenib: Analysis of data from italian spontaneous reporting database. (14th February 2016) Authors: Langella, R; Festinese, F; Re, B; Lanzo, G; Togliardi, E; Nurra, S; Antonacci, G; Di Mauro, C; Mazzer, M; Saibene, G Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. GM-019 Use of imatinib in GIST and CML: comparison of expenditure between National Cancer Institute of Milan and national expenditure. (24th February 2014) Authors: Festinese, F; Togliardi, E; Brera, F; Di Mauro, C; Lanzo, G; Bifano, F; Saibene, G Journal: European journal of hospital pharmacy Issue: Volume 21(2014)Supplement 1 Page Start: A121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗